Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0764
-0.0135 (-15.02%)
Jun 20, 2024, 12:47 PM EDT - Market open

Nascent Biotech Balance Sheet

Millions USD. Fiscal year is Apr - Mar.
Year
20222021202020192018 2017 - 2012
Cash & Equivalents
0.170.09000.13
Upgrade
Cash & Cash Equivalents
0.170.09000.13
Upgrade
Cash Growth
82.37%6479.37%-55.41%-97.55%12.37%
Upgrade
Receivables
000.7500
Upgrade
Other Current Assets
0.080.01000
Upgrade
Total Current Assets
0.260.110.7500.13
Upgrade
Total Assets
0.260.110.7500.13
Upgrade
Accounts Payable
0.50.780.640.850.53
Upgrade
Deferred Revenue
000.121.280
Upgrade
Current Debt
0.3900.160.140
Upgrade
Other Current Liabilities
0.6600.30.60.09
Upgrade
Total Current Liabilities
1.550.781.222.880.61
Upgrade
Other Long-Term Liabilities
00.78000.53
Upgrade
Total Long-Term Liabilities
00.78000.53
Upgrade
Total Liabilities
1.550.781.222.880.61
Upgrade
Total Debt
0.3900.160.140
Upgrade
Debt Growth
--16.51%--
Upgrade
Common Stock
0.130.110.10.040.03
Upgrade
Retained Earnings
-21.62-18.82-18.35-16.84-12.83
Upgrade
Comprehensive Income
0-0000
Upgrade
Shareholders' Equity
-1.3-0.67-0.47-2.88-0.48
Upgrade
Total Liabilities and Equity
0.260.110.7500.13
Upgrade
Net Cash / Debt
-0.220.09-0.16-0.140.13
Upgrade
Net Cash / Debt Growth
----12.37%
Upgrade
Net Cash Per Share
-0.000.00-0.00-0.000.00
Upgrade
Working Capital
-1.3-0.67-0.47-2.88-0.48
Upgrade
Book Value Per Share
-0.01-0.01-0.01-0.08-0.02
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.